Celldex Therapeutics Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Weaker technical forecast for Celldex Therapeutics as stock downgraded to Sell Candidate.
(Updated on Apr 16, 2024)
The Celldex Therapeutics stock price fell by -1.20% on the last day (Tuesday, 16th Apr 2024) from $39.07 to $38.60. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 2.94% from a day low at $38.15 to a day high of $39.27. The price has fallen in 6 of the last 10 days and is down by -6.22% for this period. Volume has increased on the last day by 292 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 615 thousand shares were bought and sold for approximately $23.73 million.
The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $38.38 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 9.03% during the next 3 months and, with a 90% probability hold a price between $41.84 and $59.01 at the end of this 3-month period.
CLDX Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Celldex Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $39.62 and $43.47. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -25.60%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Celldex Therapeutics stock
Celldex Therapeutics finds support from accumulated volume at $38.25 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.12 (2.94%) between high and low. For the last week, the stock has had daily average volatility of 4.56%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CLDX) For The Upcoming Trading Day Of Wednesday 17th
For the upcoming trading day on Wednesday, 17th we expect Celldex Therapeutics to open at $38.67, and during the day (based on 14 day Average True Range), to move between $36.71 and $40.49, which gives a possible trading interval of +/-$1.89 (+/-4.89%) up or down from last closing price. If Celldex Therapeutics takes out the full calculated possible swing range there will be an estimated 9.78% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $38.25 (0.91%) than the resistance at $42.01 (8.83%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Celldex Therapeutics stock A Buy?
The Celldex Therapeutics stock holds several negative signals and despite the positive trend, we believe Celldex Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -1.260 Sell Candidate Downgraded
Predicted Opening Price for Celldex Therapeutics of Wednesday, April 17, 2024
| Fair opening price April 17, 2024 | Current price |
|---|---|
| $38.67 ( 0.190%) | $38.60 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CLDX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 39.79 | 3.09 % | |
| R2 | 39.37 | 1.98 % | ||
| R1 | 39.10 | 1.30 % | ||
| Current price: | 38.60 | |||
| Support | S1 | 38.25 | -0.92 % | |
| S2 | 37.98 | -1.60 % | ||
| S3 | 37.55 | -2.71 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 48.23 | 24.95 % | |
| R2 | 48.06 | 24.51 % | ||
| R1 | 42.01 | 8.83 % | ||
| Current price | 38.60 | |||
| Support | S1 | 38.25 | -0.91% | |
| S2 | 37.75 | -2.20% | ||
| S3 | 36.38 | -5.75% |
FAQ
Click here for our free guide on how to buy Celldex Therapeutics Stock.
